Safety and Bacteraemia Between Peripherally Inserted and Central Inserted Catheters. (PYCBAC)

Randomized, Prospective, Single-center Study to Compare the Effectiveness and Safety in Terms of Catheter Bacteraemia, Between Peripherally Inserted Central Catheters and Non-tunneled Central Venous Catheter in Tertiary Hospital

Clinical, prospective, single-center, national trial. open and randomized at 1: 1 to compare the rate of bacteremia associated between non-tunneled Central venous catheter and peripheral inserted central catheter.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

247

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Barcelona, Spain, 08025
        • Hospital de la Santa Creu i Sant Pau

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male and female patients ≥ 18 years.
  • Patients hospitalized at our institution requiring at least 6 days of intravenous treatment in a conventional ward of our hospital.
  • Signed informed consent by the patient and / or when necessary parent / legal guardian.

Exclusion Criteria:

  • Patients with bacteremia at the time of catheter insertion.
  • Patients admitted to hematology or intensive care units, for considered a type of patient characteristics very different from other patients.
  • Patients with severe clinical situation.
  • Patients in whom peripheral venous access is technically impossible, patients outpatient and express refusal of the patient.
  • Pregnant patients.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental CVC
CVC insertion Non-tunneled Central venous catheter insertion
The inclusion of any CVC is an aseptic technique, so hand washing, mask, cap is required, sterile gloves and scoping insertion using sterile drapes. The skin disinfection is carried out with 2% chlorhexidine alcohol 17, to be dried completely before insertion of the catheter (30 seconds). No prophylactic antibiotic was administered before insertion. In the case of CVC, the subclavian vein of choice will be followed by the femoral and jugular. Seldinger technique with direct radiation control in the operating room is used.
Experimental: Experimental PICC
PICC insertion Peripherally inserted catheter
The inclusion of any PICC is an aseptic technique, so hand washing, mask, cap is required, sterile gloves and scoping insertion using sterile drapes. The skin disinfection is carried out with 2% chlorhexidine alcohol 17, to be dried completely before insertion of the catheter (30 seconds). No prophylactic antibiotic was administered before insertion. PICC vein of choice is the basilica vein with help of Ecography in the interventional radiology room.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with Bacteraemia
Time Frame: 30 days
Number of participants with Bacteraemia from insertion until 30 days after remove of the catheter
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
morbidities in catheter insertion
Time Frame: 1 day
Number of participants with complications during catheter insertion
1 day
Comparison of morbidities during manipulation of the catheters
Time Frame: 30 days
Number of participants with complications during manipulation of the catheters
30 days
30 days Mortality
Time Frame: 30 days
Number of died participants
30 days
Visual analogic scale of Pain
Time Frame: 30 days
Visual analogic scale of Pain in site of insertion from insertion until remove of the catheter
30 days
Health-care costs
Time Frame: 30 days
Economic study of the whole procedure including complications
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 2, 2015

Primary Completion (Actual)

June 11, 2017

Study Completion (Actual)

July 11, 2017

Study Registration Dates

First Submitted

April 23, 2015

First Submitted That Met QC Criteria

September 1, 2015

First Posted (Estimate)

September 2, 2015

Study Record Updates

Last Update Posted (Actual)

October 25, 2018

Last Update Submitted That Met QC Criteria

October 23, 2018

Last Verified

October 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Catheter Related Infections

Clinical Trials on CVC

3
Subscribe